SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-14-039639
Filing Date
2014-06-25
Accepted
2014-06-25 20:20:47
Documents
1
Period of Report
2014-06-23

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v382342_4.html 4  
1 OWNERSHIP DOCUMENT v382342_4.xml 4 42810
  Complete submission text file 0001144204-14-039639.txt   44261
Mailing Address C/O CHELSEA THERAPEUTICS, INC. 13950 BALLANTYNE CORPORATE PL SUITE 325 CHARLOTTE NC 28277
Business Address
Riehle J Nick (Reporting) CIK: 0001316746 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51462 | Film No.: 14941162

Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Issuer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences